SELP+ TEC:CD8+ T cell crosstalk associates with improved radiotherapy efficacy in cervical cancer
- Qingyu Huang 1, Wenhui Yang 2, Fuhao Wang 1, Rui Huang 3, Qian Wang 2, Xiaohui Li 4, Tianyu Lei 2, Shengqin Yue 2, Wenxue Zou 1,5, Qi An 2, Jinbo Yue 6, Qinyong Hu 7,8, Chao Liu 9
- Qingyu Huang 1, Wenhui Yang 2, Fuhao Wang 1
- 1Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, 250117, China.
- 2Department of Oncology, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
- 3Department of Oncology, Chongqing University Fuling Hospital, Chongqing, China.
- 4Department of Medical Oncology, Peking University First Hospital, Beijing, China.
- 5Department of Oncology, Linyi Center Hospital, Linyi, Shandong, China.
- 6Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, 250117, China. jbyue@sdfmu.edu.cn.
- 7Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, 250117, China. rm001223@whu.edu.cn.
- 8Department of Oncology, Renmin Hospital of Wuhan University, Wuhan, 430060, China. rm001223@whu.edu.cn.
- 9Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, 250117, China. charles.liu@whu.edu.cn.
- 0Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, 250117, China.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.P-selectin (SELP) expressed in cervical cancer endothelial cells enhances anti-cancer immunity and improves radiotherapy outcomes. Targeting SELP+ endothelial cells and CD8+ T cell interactions may overcome treatment resistance.
Area Of Science
- Oncology
- Immunology
- Cell Biology
Background
- P-selectin (SELP) in tumor cells is linked to cancer progression and treatment resistance.
- SELP expression in cervical cancer (CC) endothelial cells may influence anti-cancer immunity and radiotherapy response.
- Mechanisms of SELP's role in CC immunity and radiotherapy remain unclear.
Purpose Of The Study
- Investigate the role of SELP in tumor endothelial cells (TECs) in CC radiotherapy response.
- Elucidate the mechanisms by which SELP influences anti-cancer immunity.
- Determine the association between SELP expression and patient survival outcomes.
Main Methods
- Analysis of tumor tissue samples from 205 CC patients undergoing radiotherapy.
- Single-cell RNA sequencing (scRNA-seq) of 42,159 cells from eight CC patients.
- Bulk RNA sequencing of 187 radiotherapy-treated CC patients.
Main Results
- Elevated SELP expression in TECs correlated with improved radiotherapy survival outcomes.
- SELPhigh group showed enriched immune pathways and reduced proliferation/angiogenesis.
- Increased CD8+ T cell infiltration and ACKR1 expression were observed in SELPhigh tumors.
- SELP+ TECs and CD8+ T cells interact via the ACKR1-CCL5 axis, enhancing radiotherapy efficacy.
Conclusions
- SELP+ TECs play a crucial role in enhancing CC radiotherapy response through interaction with CD8+ T cells.
- The ACKR1-CCL5 pathway mediates the crosstalk between SELP+ TECs and CD8+ T cells.
- Targeting this SELP+ TEC:CD8+ T cell crosstalk offers potential therapeutic strategies against treatment resistance in CC.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
01:27
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:57
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

